SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers.

Li, Xue-Ping; Huang, Xin; Qin, Yan-Mei; Wu, Guo-Yan; Liang, Cheng-Cai; Dai, Yu-Jun; Zhang, Wei-Na

Li, Xue-Ping; Huang, Xin; Qin, Yan-Mei; Wu, Guo-Yan; Liang, Cheng-Cai; Dai, Yu-Jun; Zhang, Wei-Na.

Li XP; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Huang X; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Qin YM; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wu GY; Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liang CC; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
Dai YJ; Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang WN; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Clin Transl Med ; 11(2): e345, 2021 02.

Article in English | MEDLINE | ID: covidwho-1095259

Subject(s)

COVID-19/immunology; Membrane Proteins/immunology; Neoplasms/immunology; RNA-Binding Proteins/immunology; SARS-CoV-2/immunology; Tumor Microenvironment/immunology; A549 Cells; COVID-19/pathology; Female; Humans; Male; Neoplasms/pathology; Neoplasms/virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA-Binding Proteins / Tumor Microenvironment / SARS-CoV-2 / COVID-19 / Membrane Proteins / Neoplasms Limits: Female / Humans / Male Language: English Journal: Clin Transl Med Year: 2021 Document Type: Article Affiliation country: Ctm2.345

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google